Inflammation and Immunity in Cancer
This book overviews cancer immunity from broad scientific fields, based on the concept that cancer is a sort of by-product of infection, inflammation, and host immune response. The innate and acquired arms of the immune system mainly participate in tumor immune surveillance, and their activation is...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , , , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Tokyo :
Springer Japan : Imprint: Springer,
2015.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Preface
- 1 Role of bone marrow-derived CCR1+ cells in colon cancer invasion and metastasis.- 2 PGE2-associated inflammation and gastrointestinal tumorigenesis
- 3 Regulation of tumor-associated myeloid cells by innate immune signaling
- 4 The role of PIKfyve in TLR-mediated inflammation and immune responses
- 5 Emerging roles of an innate immune regulator TAPE in the Toll-like receptor and RIG-I-like receptor pathways
- 6 Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T-cell leukemia/lymphoma cells
- 7 Tumor-associated molecular patterns: its implication in tumoricidal inflammation
- 8 Host factors involved in the propagation and pathogenesis of hepatitis C virus.- 9 HCV-induced inflammation: The role of cross-talk between HCV-infected hepatocytes and stellate cells
- 10 Development of immunotherapy for hepatocellular carcinoma
- 11 Development of glypican-3-targeted cancer immunotherapy
- 12 The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation
- 13 In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy
- 14 Enhancement of efficacy of WT1 peptide cancer vaccine by co-administration with immunopotentiating agents: Lessons from mouse models
- 15 Regulation of antigen-presentation by dendritic cells and its application to cancer immunotherapy
- 16 A new mode of CTL induction secondary to alteration of pMHCI repertoire by antigen processing defects
- 17 Progress in clinical use of CCR4 antibody for regulatory T cell suppression
- 18 Adjuvant Immunotherapy for cancer: Basic research to clinical bench
- 19 Immunological regulation of human cancer stem cell/cancer-initiating cells (CSC/CIC)
- 20 Overview on tumor immunology.-BM Epilogue.
